A technique that induces imaginary sounds in both mice and people could help scientists understand the brain circuits involved in schizophrenia and other disorders that cause hallucinations.
Alzheimer’s researchers, aerosol engineer team up to develop rapid screening tools
Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19
Study indicates the drug is effective in opioid users who also take benzodiazepines for anxiety, other conditions
$5 million grant to fund saliva tests for students, teachers, staff in schools operated by Special School District of St. Louis County
Antidepressant drug repurposed for patients with coronavirus infection
As more states enact laws legalizing pot, addiction problems may increase
Multi-university study shows app can help students reduce symptoms, ease depression
Such delays lead to serious disparities in access to developmental therapy
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.